• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.





    Your Distributor Permit will expire on May 31, 2021.  To renew your distributor permit online, visit the online renewal site at: https://mdbop.mylicense.com/eGov/PersonSearchResults.aspx?Facility=Y

    The renewal period begins on March 15, 2021.

    All Distributors including Wholesale Distributors, Manufacturers and Virtual Manufacturers Distributing Their Own Prescription Drugs or Devices may renew online.  Only Visa or MasterCard are accepted as forms of payment for the online renewal. 

    You may also renew by downloading and submitting a paper renewal application along with a check or money order.

    A completed application postmarked or received by the Board on or before May 31, 2021, must be accompanied by a $1,750.00 renewal fee.  Applications postmarked after May 31, 2021, are subject to a $3,250.00 fee ($1,750 renewal fee plus $1,500 reinstatement fee). 

    PLEASE NOTE:  You must submit a substantially completed application at least 14 days before May 31, 2021, to guarantee an uninterrupted period of licensure.  If you submit your application between May 18 and May 31, 2021, your permit may lapse before processing is complete, and you may be subject to an additional reinstatement fee.

    For more information and instructions on the online renewal process, please contact the Board via email: mdh.mdbop@maryland.gov.

    The completed renewal application may be mailed, along with a check or money order, to:
    Maryland Board of Pharmacy, P.O. Box 2024, Baltimore, MD 21203-2024
    Applications sent overnight or through priority mail must be addressed to:
    Wells Fargo Bank, Attn: State of MD – Board of Pharmacy, Lockbox 2024
    7175 Columbia Gateway Drive, Columbia, MD 21046


     Wholesale Distributors can now renew online by clicking here.

    View tutorials on the online renewal process by clicking here

    Background Check Information: Click Here


    The Maryland Board of Pharmacy requires Accreditation for companies residing in states that do not have requirements that are 'substantially equivalent to Maryland’s wholesale distributor requirements.' 

    Distributors may obtain NCDQS QAS Accreditation.
    National Coalition for Drug Quality & Security 8 The Green, Suite A, Dover, DE 19901 info@ncdqs.org Denise M. Frank, RPh
    Director of Accreditation and Inspection Services

    All applications and correspondence related to the processing of applications and related documents for the Maryland Board of Pharmacy shall be sent to the following mailing addresses:
    Pharmacies, Distributors, Manufacturers (new, renewal, and reinstatement), Non-Resident Pharmacy (new, renewal, reinstatement), Pharmacy Waiver (new, renewal, and reinstatement), and any related correspondence:
    Maryland Board of Pharmacy
    P O Box 2024
    Baltimore, MD 21203-2024
    Applications sent overnight or by priority mail should be addressed to the appropriate lockbox and sent to:
    Wells Fargo Bank
    Attn: State of MD – Board of Pharmacy
    Lockbox 2024
    401 Market Street
    Philadelphia, PA 19106
    NOTE:  Applications and forms shall be completed in their entirety and the appropriate payment attached and sent to the appropriate P.O. Box.  Payments in the form of cash or money order will not be accepted at the Board of Pharmacy on a walk-in basis; however, the Board will accept credit card payments. Please make sure to download the current application from the Board’s website. The Board of Pharmacy will no longer accept outdated applications. If you submit an outdated application, it will be returned and will delay the processing of your application. All documents and correspondence related to Compliance, Investigations, and Inspections will be sent directly to the Board of Pharmacy at 4201 Patterson Avenue, Baltimore, MD 21215-2299.


    Click Here For Establishment Forms

    Additional Links

    Sterile Compounding Adverse Event Reporting


    Theft or Loss of Controlled Substances Report


    Formal Board Orders / Disciplinary Actions

    Professional Programs

    For more information about the new DME/Device Only Pharmacy Law Change
    Click HERE

    Inspection Forms


    Important Sterile Compounding Information
    The Sterile Compounding Permit Program was repealed during the 2015 Legislative Session by the passage of SB 69/HB 181 entitled “State Board of Pharmacy – Sterile Compounding – Compliance by Nonresident Pharmacies and Repeal of Permit Requirement,” effective April 14, 2015. Therefore, there is no separate permit required for a pharmacy performing sterile compounding pursuant to a patient specific prescription. 
    Click HERE for more information